US 12391720
Salts and polymorphs of cethromycin for the treatment of disease
granted A61KA61K31/7048A61K31/706
Quick answer
US patent 12391720 (Salts and polymorphs of cethromycin for the treatment of disease) held by AliquantumRx, Inc. expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AliquantumRx, Inc.
- Grant date
- Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/7048, A61K31/706, A61P, A61P31/04